Dr. Walter Gotlieb
- Professor, Department of Obstetrics and GynecologyÂ
- Professor, Department of OncologyÂ
- Director of Surgical OncologyÂ
- Director of Gynecologic-OncologyÂ
- Head, Heriditary Ovarian Cancer UnitÂ
MD, PhD
Currently supervising students
- Investigating rare gynecological cancers through high-throughput sequencing of tumors supported by the Terry Fox – Marathon of Hope Initiative and the development of a national Rare Cancer Registry through the Society of Gynecologic Oncology of Canada and Ovarian Cancer CanadaÂ
- Investigating the role of Interleukin-10 in Ovarian CancerÂ
- Development of a new DNA repair protein biomarker (PARG) in ovarian cancer to determine response to treatment.Â
- Determining the role of PARP inhibitors and Homologous recombination deficiency status in endometrial cancersÂ
- Identification of New Molecular Subgroups of High-Grade Serous Ovarian Carcinoma treated with Neoadjuvant Chemotherapy: impact on prognosis and therapy.Â
- Investigate the value of robotic surgery for patients with gynecologic cancers.Â
Robotic surgery, Gynecologic CancersÂ
Ovarian cancer, Translational Research, IGF ReceptorÂ
Dr Gotlieb obtained his MD summa cum laude in 1984, PhD and certification in Ob-Gyn in 1991at ULB, in his native Belgium. After 2 years at the NIH, he obtained the National Cancer Institute Award of Outstanding Performance, and performed a three year fellowship in Gynaecologic-oncology at UCLA. In 1994 he co-founded the Department of Gynaecologic-Oncology at Tel Aviv University, where he continued his clinical research until 2003, when he was recruited by McGill University. He obtained license to practice in Europe, Israel, California, and Canada. He is Project Director at the LDI Research Institute. Together with his team, and particularly Dr. Lau, they have been the pioneers of “robotic” surgery in gynaecologic oncology in Canada. He has lectured around the world, and has proctored robotic surgery in Canada, China, India, and Israel. A recipient of thirteen national and international awards in the area of cancer research, Dr. Gotlieb is well published with 150 peer-reviewed manuscripts in reputable international journals and book chapters. Dr. Gotlieb is President of the Gynecologic Oncology Society of Canada, secretary treasurer of the International Gynecologic Cancer Society and senior editor of the International Journal of Gynecologic Cancer. His prior involvements with medical societies include the council of the International Gynecologic Cancer Society, the Israel Gynecologic Oncologists,  secretary treasurer of the Society of Gynecologic Oncologists of Canada, the SGO program committee, the International Committee of the SGO, and Vice President of the Association des GynĂ©cologues Oncologues du QuĂ©bec. He recently completed an executive course in health care management and delivery at the Harvard Business School.  Â